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A B S T R A C T
Background: Previous studies on patients with Multiple Sclerosis (MS) have reported contrasting findings on
cortical plasticity of the primary motor cortex and no study has yet evaluated the regulatory mechanisms of
cortical plasticity (i.e., metaplasticity) in MS patients. The aim of the present study was to investigate primary
motor cortex (M1) plasticity and metaplasticity in patients with MS.
Methods: Nineteen patients affected by Relapsing-–Remitting MS (RR-MS) and 16 age- and sex-matched healthy
controls underwent intermittent Theta Burst Stimulation (iTBS) to evaluate cortical plasticity and iTBS preceded
by repetitive index finger movements to evaluate M1 metaplasticity.
Results: In healthy subjects MEP size significantly increased after iTBS whereas it significantly decreased when
repetitive index finger movements preceded iTBS (metaplasticity) (factor PROTOCOL: p<0.0001; PROTOCOL x
TIME interaction: p=0.001). Conversely, in MS patients MEP size mildly increased, albeit not significantly in
both conditions (p>0.05). In MS patients, percentage changes in MEP size induced by plasticity and meta-
plasticity protocol were significantly associated to EDSS (p=0.001) and kinematics of index finger movements
(p=0.01).
Conclusion: M1 plasticity and metaplasticity are both altered in MS patients. When TBS is used for therapeutic
purposes, TBS protocols should be tailored according to the M1 plasticity functional reserve of each MS patient.
1. Introduction
Studies in humans have shown that when repetitive transcranial
magnetic stimulation (rTMS) is delivered over the primary motor cortex
(M1), it induces long-lasting changes in the amplitude of motor evoked
potentials (MEP), reflecting mechanisms of cortical plasticity
(Ziemann et al., 2008). In healthy subjects the rTMS-induced effects on
M1 largely depend on regulatory mechanisms of cortical plasticity.
Metaplasticity is one of the regulatory mechanisms ensuring that sy-
naptic plasticity remains within physiological and dynamic ranges, al-
lowing learning of new tasks (Abraham and Bear, 1996).
In patients with Multiple Sclerosis (MS) several studies have in-
vestigated cortical plasticity by means of various rTMS protocols but
the results on cortical plasticity in MS are still controversial
(Zeller et al., 2012; Mori et al., 2011, 2012, 2013, 2016; Conte et al.,
2016; Wirshing et al., 2018). The authors who reported increased
cortical plasticity or paradoxical excitatory after-effects induced by
rTMS (Mori et al., 2013, 2014), suggested that the inflammatory ex-
citotoxic damage (Mori et al., 2012, 2014) may be responsible for
abnormal plasticity mechanisms in MS patients. Recent studies have
also suggested that rTMS (Iodice et al., 2017) may be used as a ther-
apeutic strategy to improve motor functions in these patients
(Centonze et al., 2007; Mori et al., 2009, 2010; Boutière et al., 2017). It
is possible that in patients with MS inflammatory damage not only af-
fects cortical plasticity but also its regulatory mechanisms, namely
cortical metaplasticity. Understanding whether regulatory mechanisms
of cortical plasticity are altered in MS has important implications when
rTMS protocols are to be applied for therapeutic purposes.
In order to determine whether cortical plasticity in MS is altered
and, if so, whether the alteration is related to impaired regulatory
mechanisms of plasticity, i.e., metaplasticity, we investigated both
cortical plasticity and cortical metaplasticity mechanisms in a cohort of
Relapsing–Remitting MS (RRMS) patients. The results were compared
with those from a control group of healthy subjects.
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2. Material and methods
2.1. Subjects and clinical assessment
Nineteen RRMS patients were consecutively enrolled in the study
and 16 age- and sex-matched healthy controls (HC) acted as control
group. The participants’ demographic and clinical characteristics are
reported in Table 1. The inclusion criteria were age over 18 years; di-
agnosis of MS according to the McDonald criteria (Polman et al., 2011);
no disease relapse or corticosteroid intake in the last 30 days; Mini-
Mental State Examination (MMSE) >28; Expanded Disability Status
Scale (EDSS) ≤4 (Kurtzke, 1983). All the patients enrolled were on
Disease Modifying Drugs (DMDs). The study was approved by the Ethics
Committee of Policlinico Umberto I, Sapienza University of Rome, and
was conducted in accordance with the Declaration of Helsinki. Written
informed consent was obtained from every participant before the be-
ginning of the study.
2.2. Neurophysiological assessment: stimulation techniques
Subjects were studied in two experimental sessions separated by
approximately one week. All the participants were comfortably seated
in an armchair. Single TMS pulses were delivered by means of a
monophasic Magstim stimulator and intermittent Theta Burst
Stimulation (iTBS) was delivered by means of a biphasic Super Rapid
Magstim 200 magnetic stimulator (Magstim, Whitland, Dyfed, UK).
Both stimulators were connected to a figure eight coil (external wing
9 cm in diameter) placed tangentially over the scalp with the handle
pointing back and away from the midline at 45°, which is the optimal
position for eliciting MEP in the contralateral target muscle (first dorsal
interosseous–FDI- in the dominant hand).
Motor thresholds, which were calculated in both sessions at rest
(Resting Motor Threshold - RMT), were defined as the lowest stimulus
intensity able to evoke a MEP of an amplitude of ≥ 50 μV in 5 out of 10
consecutive trials, and during a slight voluntary contraction (Active
Motor Threshold -AMT) of the target muscle (20%–30% of the max-
imum voluntary contraction), which was defined as the lowest intensity
able to evoke a MEP of ≥ 200 V in 5 out of 10 consecutive trials. The
intensity of the single-pulse TMS used to monitor changes in cortical
excitability was set so as to obtain a mean MEP size of 1mV at the
baseline. iTBS, which was applied according to a previously described
technique (Huang et al., 2005; Iezzi et al., 2008, 2011), consisted of
bursts given in short trains lasting 2 s (i.e., 10 bursts) repeated every
10 s for a total number of 600 pulses (i.e., 20 trains). iTBS was delivered
at 80% of the AMT intensity.
2.3. EMG recording
Electromyographic (EMG) activity was recorded through a pair of
Ag/AgCl electrodes placed over the FDI muscle in a belly-tendon
fashion. The raw EMG signal was amplified and filtered (bandwidth:
20 Hz–1 kHz) by means of a Digitimer D360 amplifier (Digitimer) and
sampled at 5 kHz (CED 1401 A/D laboratory interface, Cambridge
Electronic Design, Cambridge, UK). Data were stored on a laboratory
computer for on-line visual display and for further off-line analysis
(Signal software, Cambridge Electronic Design). EMG activity of the
target muscle was monitored throughout the experimental sessions by
using an audio and high-gain visual feedback to ensure the complete
relaxation of the target muscles. Baseline MEP size was measured peak-
to-peak. MEP size after movements and after TBS was expressed as a
percentage of the baseline MEP.
2.4. Motor task and movement recording
Participants were comfortably seated in an armchair beside a table.
The arm was abducted at the shoulder by about 45–50°, and the elbow
joint was flexed at about 90° After a verbal “go” signal, subjects ab-
ducted the index finger, then returned the finger to the starting position
upon being given a verbal “stop” signal shortly after. Each subject
performed 30 index finger abductions, preceded by 3 or 4 training
movements. Subjects were instructed to perform movements “as widely
and as quickly as possible” after the verbal command and were con-
tinually encouraged to do so throughout the motor task. Index finger
movements in the three-dimensional space were recorded by means of
the SMART analyzer motion system (BTS Engineering, Milan, Italy),
which contains three infrared cameras (sampling rate, 120 Hz) that
follow the displacement of a passive marker taped on the distal phalanx
of the subject's right index finger. A dedicated software was used to
reconstruct the displacement of the passive marker off-line and auto-
matically determine the kinematic features of each movement. The
same software was used to measure Range Of Motion (ROM) and an-
gular speed (Conte et al., 2017, 2018).
2.5. Experimental paradigm
The experimental procedures consisted in two sessions whose order
of presentation was pseudorandomized across subjects.
2.5.1. Cortical plasticity protocol
In this session, we tested the effects of iTBS on the motor cortex
plasticity by using single TMS pulses delivered at rest over the FDI
motor cortical hot spot before (baseline, T0) and 5 (T1), 15 (T2) and
30min (T3) after iTBS. We collected 10 MEPs at each time point.
2.5.2. Metaplasticity protocol: effects of index finger movements on iTBS
after-effects
In this session, we investigated the effects of index finger move-
ments on iTBS-induced after-effects. Single TMS pulses were delivered
before (T0), immediately after index finger movements (MEP post-mov)
and 5 (T1), 15 (T2) and 30min (T3) after iTBS. We also evaluated
motor performance during the task by using a kinematic analysis to
measure the mean amplitude and mean peak velocity of index finger
abductions.
2.6. Statistical analysis
We used the SPSS 25.0 toolbox (version 25, IBM, New York, USA)
Table 1
Demographic and clinical features of patients with relapsing–remitting multiple
sclerosis.
Age (years) Gender Disease duration
(years)
EDSS DMD
1 37 F 9 4 Teriflunomide
2 40 M 10 1 Dimethylfumarate
3 32 F 3 3 Dimethylfumarate
4 24 F 1 3,5 Dimethylfumarate
5 51 M 14 2 IFNβ−1a 44 mcg sc
6 48 F 28 0 Dimethylfumarate
7 32 M 17 2 Dimethylfumarate
8 46 F 23 2,5 IFNβ−1a 44 mcg sc
9 30 F 2 2 Dimethylfumarate
10 57 F 19 3 IFNβ−1a 30 mcgim
11 37 M 10 1 IFNβ−1a 44 mcg sc
12 33 F 10 3 Fingolimod
13 36 F 1 1 IFNβ−1a 44 mcg sc
14 34 F 4 0 Dimethylfumarate
15 35 F 6 1 IFNβ−1a 44 mcg sc
16 25 F 3 1,5 Fingolimod
17 45 F 3 1 Teriflunomide
18 45 F 4 4 Dimethylfumarate
19 42 F 15 4 Dimethylfumarate
Abbreviations: F: female; M: male; EDSS: Expanded disability Status Scale;
DMD: disease modifying drug.
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for all the statistics. Group comparisons were tested by means of the
Shapiro-Wilks test to evaluate whether distribution was Gaussian or
not, and parametric (Repeated measure ANOVA, One-way ANOVA) or
non-parametric tests (Mann–Whitney U test) were used accordingly.
For the analysis of the neurophysiological data, we used a between-
groups ANOVA to compare the kinematic parameters of the index finger
movements (ROM, mean angular velocity and time) and TMS variables
(AMT, intensity to evoke 1mV MEP amplitude) between MS patients
and healthy subjects. We then compared percentage changes in MEP
amplitude induced by iTBS (plasticity protocol) and iTBS preceded by
index finger movements (metaplasticity protocol) in MS patients and
healthy subjects using a repeated measures ANOVA with factor GROUP
(2 levels: MS vs. healthy) and factors PROTOCOL (2 levels: iTBS vs.
iTBS preceded by index finger movements) and TIME (baseline, T1, T2,
T3).
Correlations (Pearson's correlation coefficient) and a linear regres-
sion analysis were performed to investigate any association between the
neurophysiological and clinical variables. Pearson's correlation coeffi-
cient was also performed to investigate any association between mean
percentage changes in MEP amplitude induced by plasticity and me-
taplasticity interventions. All the results are reported at p<0.05 after
FDR correction for multiple comparisons.
3. Results
3.1. TMS variables at baseline and kinematic parameters in MS patients and
healthy subjects
One-way ANOVA showed a similar baseline MEP amplitude in MS
patients and healthy subjects (p=0.77), though AMT and intensity for
1mV MEP were higher in MS patients than in healthy subjects
(p<0.05). One-way ANOVA also showed that the kinematic para-
meters (ROM, mean angular velocity and time) of index finger move-
ments were similar in MS and healthy subjects (all ps> 0.05).
3.2. Changes in MEP amplitude induced by the cortical plasticity and
metaplasticity protocol in MS patients and healthy subjects
Repeated measures ANOVA for MEP amplitude percentage changes
revealed a significant factor PROTOCOL (F=5.4, p=0.02), a sig-
nificant GROUP x PROTOCOL interaction (F=5.7, p=0.02) and a
significant GROUP x PROTOCOL x TIME interaction (F=2.8,
p=0.04). Post-hoc analysis showed that the MEP amplitude in healthy
subjects increased after iTBS but decreased when index finger move-
ment preceded iTBS (factor PROTOCOL: F=24.6, p<0.0001; PROT-
OCOL x TIME interaction: F=6.6, p=0.001) (Fig. 1).
By contrast, the MEP amplitude in MS patients increased in both
sessions, albeit not significantly (all ps>0.05) (see Fig. 2).
Linear regression analysis showed that the changes in the MEP
amplitude between the two sessions (mean percentage changes in MEP
amplitude in the “metaplasticity” session/mean percentage changes in
MEP amplitude in the “cortical plasticity” session) were significantly
associated with the EDSS score (t=4.34, p=0.001) (see Fig. 3), mean
angular velocity (t=−2.47, p=0.02) and duration of the index finger
movements (t=−2.9, p=0.01), though not with AMT or intensity for
1mV MEP.
No correlation was detected between MEP changes induced by the
“cortical plasticity” and “cortical metaplasticity” protocols in MS pa-
tients (p>0.05).
3.3. Effect of the motor task on plasticity in the primary motor area
Repeated measures ANOVA revealed a significant factor “motor
TASK” (F=5.6; p=0.02) though not a significant factor “Group”
(F=0.53, p=0.39) and MOTOR TASK x GROUP interaction (F=1,7;
p=0.2), which indicates that the increase in MEP amplitude
immediately after the index finger movements was similar in MS pa-
tients and healthy controls.
4. Discussion
Two main findings emerge from our study. The first is that following
iTBS over M1 the MEP amplitude increased to a lesser extent in MS
patients (plasticity protocol) than in healthy subjects. The second
finding is that when the repetition of voluntary index finger abductions
preceded iTBS (metaplasticity protocol), the MEP amplitude decreased
in healthy subjects (Iezzi et al., 2008) whereas in MS patients it in-
creased slightly. Taken together, these results suggest that both plasti-
city and metaplasticity in M1 are altered in MS patients.
When the experimental procedure was designed, various precau-
tions were taken to avoid methodological errors that might bias the
interpretation of the neurophysiological results. All the MS patients
were studied in a remitting phase to ensure that the neurophysiological
measurements were performed with the patients in a similar clinical
phase. Moreover, all the subjects were studied under the same experi-
mental conditions and at the same time of day in order to reduce any
variability caused by circadian rhythms. The experimental sessions took
place at least one week apart to exclude take-over effects
(Bienenstock et al., 1982; Siebner et al., 2009). The subjects were in-
structed to relax completely in order to avoid any muscle contractions
that might alter the MEP size (Huang et al., 2008), and we continuously
Fig. 1. Percentage changes in motor evoked potential (MEP) amplitude induced
by intermittent Theta Burst Stimulation (iTBS) (plasticity protocol) and iTBS
preceded by index finger movements (metaplasticity protocol) in healthy sub-
jects.
Fig. 2. Percentage changes in motor evoked potential (MEP) amplitude induced
by intermittent Theta Burst Stimulation (iTBS) (plasticity protocol) and iTBS
preceded by index finger movements (metaplasticity protocol) in patients with
multiple sclerosis (MS).
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monitored the patients’ EMG activity in the target muscles by means of
visual and auditory feedback. During the motor task all the subjects
were continually encouraged to perform the task “as widely and as
quickly as possible” so as to ensure the correct execution and reliability
of the subsequent analysis of the kinematic parameters of the move-
ment itself. Although the stimulation intensity required to evoke both
1mV MEP and AMT was higher in MS patients than in healthy subjects,
which points to reduced cortical excitability in M1 in the former, the
stimulation performed at baseline elicited 1mV MEP in both the MS
patients and healthy subjects. In addition, the intensities used in MS
patients fell within a range corresponding to approximately half of the
maximum power of the stimulator. We therefore believe that the altered
cortical plasticity we detected following iTBS in MS does not depend on
the stimulation intensity.
4.1. Cortical plasticity in MS patients and in healthy subjects
Previous studies have reported normal iTBS-induced cortical plas-
ticity in stable RR-MS patients but a loss of plasticity during relapses in
RR-MS patients and in primary progressive-MS (Mori et al., 2012,
2013). Other authors have instead reported normal plasticity
(Zeller et al., 2010, 2012). Here we found that cortical plasticity is
abnormal when RR-MS patients are studied in the remitting phase. The
discrepancies in the findings between the various studies may be as-
cribed to several factors. Most previous studies performed on MS pa-
tients did not include a control group and the intensity of TMS stimu-
lation was set so as to obtain a varying MEP amplitude range at baseline
(0.5–1mV) (Mori et al., 2013). In addition, patients were classified as
“responders to rTMS protocol” when the ratio between the mean per-
centage changes in MEP size post-iTBS and the mean percentage
changes in MEP size at baseline was higher than “1″. By applying the
same methodology, the MS patients we studied were normal in terms of
cortical plasticity, whereas their response to iTBS was reduced if com-
pared with that of healthy controls. A MEP ratio higher than “1″ does
not, therefore, necessarily imply normal iTBS-induced plasticity. The
discrepancies in the cortical plasticity findings in MS patients between
different studies may thus depend on methodological issues.
The reduced response to iTBS over M1 observed in our MS patients
is likely to depend on altered ion-channel activation (Ziemann et al.,
2008). As demonstrated in animal models of MS (Experimental Auto-
immune Encephalomyelitis -EAE) (Stampanoni Bassi et al., 2017),
proinflammatory cytokines lead to marked changes in synaptic func-
tioning and to an ion channel dysfunction from the earliest stages of the
disease (Arnold et al., 2015). Inflammation in MS subverts the
physiological balance between excitatory and inhibitory transmission
and results in enhanced glutamatergic activation, which seems to play a
key role in disease progression and in the establishment of the neuro-
degenerative process (Centonze et al., 2010; Rossi et al., 2012).
One possible explanation for cortical plasticity alterations in MS is,
as has previously been suggested (Rossi et al., 2012; Nisticò et al.,
2013), the presence of a widespread inflammatory microenvironment
that reduces GABAergic inhibitory transmission to the benefit of NMDA
receptor-mediated excitatory glutamate transmission. This persistent
glutamate NMDA receptor activation leads to neurotoxic processes that
worsen neuronal dysfunction, as has been shown in numerous degen-
erative disorders including amyotrophic lateral sclerosis and Alzhei-
mer's disease (Matute, 2011; Kostic et al., 2017). Moreover, glutamate
excitotoxicity may lead to abnormalities in LTP-like cortical plasticity,
as tested by means of rTMS techniques, that resemble those reported in
Alzheimer's disease (Di Lazzaro et al., 2002; Nardone et al., 2014).
4.2. Metaplasticity in MS patients and healthy subjects
The metaplasticity protocol used in MS patients in our study yielded
opposite effects to those observed in healthy subjects. Since the kine-
matic parameters (ROM, mean angular velocity and time) of the index
finger movements preceding the iTBS cortical plasticity induction in MS
patients were comparable to those in healthy controls, we rule out the
possibility that the lack of metaplastic effect was due to poor motor
performance. Moreover, the observation of a similar degree of post-
movement MEP amplitude facilitation in healthy subjects and MS pa-
tients confirms that MS patients effectively performed index finger
movements and motor practice. We may also assume that the post-
movement facilitation mechanisms in the MS patients we studied,
whose level of clinical impairment was shown to be low by the EDSS,
were functionally intact.
In healthy subjects, the execution of short sequences of repeated
movements reverses the polarity of cortical excitability through me-
chanisms that depend on the activation of voltage-controlled calcium
channels and are termed “polarity-reversing metaplasticity” (Gentner
et al., 2008; Iezzi et al., 2008). The physiological function of cortical
metaplasticity, also defined as “plasticity of synaptic plasticity”, is that
of maintaining neuronal synaptic plasticity within a dynamic range of
activity (Abraham and Bear, 1996), thus stabilizing neuronal activity.
According to the Bienenstock–Cooper–Munro theory, the induction
threshold of LTP and LTD is dynamically adapted according to the
previous post-synaptic activity level through homeostatic mechanisms,
thereby preventing excessive expression of LTP or LTD. Our
Fig. 3. Association between mean percentage changes in Motor Evoked Potential (MEP) amplitude between the two experimental sessions and Expanded Disability
Status Scale (EDSS).
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observations now suggest that not only mechanisms of plasticity but
also those of metaplasticity are altered in MS patients.
4.3. Relationship between cortical plasticity and metaplasticity
By testing both plasticity and metaplasticity protocols in the same
patients, we observed that the extent of the MEP changes induced by
the plasticity protocol was not linearly related to that induced by the
metaplasticity protocol. Although plasticity and metaplasticity me-
chanisms share several molecular and cellular pathways (Yee et al.,
2017; Li et al., 2018; Henderson et al., 2018), they may be affected by
the pathophysiological mechanisms with different temporal and spatial
ranges. Indeed, while metaplasticity mechanisms occur over a very slow
time course and involve all the synapses of a neuron so as to ensure the
stability and synchronize the firing rate of a neuronal population, sy-
naptic plasticity may occur over a very short period and affect in-
dividual synapses (homosynaptic mechanism) (Yee et al., 2017;
Henderson et al., 2018).
4.4. Relationship between cortical plasticity and metaplasticity with motor
performance
The other noteworthy finding of the present study is that there is an
association in MS patients between changes in MEP amplitude between
the two sessions (iTBS and iTBS preceded by movement) and both the
EDSS scores and the kinematic movement parameters (angular velocity
and duration of movement). This association may reflect abnormal non-
homeostatic cortical plasticity induced by motor learning (Halsband
and Lange, 2006). Although the kinematic properties MS patients use to
perform index finger abductions are similar to those adopted by healthy
subjects, a better execution of the motor task preceding the delivery of
the iTBS paradigm in individual patients may result in a greater degree
of metaplasticity. This finding therefore suggests that the extent of
metaplasticity is associated not only with the clinical severity of the
disease as expressed by the EDSS, but also with motor performance and
the kinematic parameters of the motor task.
5. Conclusion
In conclusion, the present study shows that M1 plasticity and me-
taplasticity mechanisms are altered in patients with MS. To place our
findings within a clinical perspective, the application of rTMS protocols
in MS to “boost” rehabilitative strategies should be tailored to each
patient since the effects of the rTMS protocol in MS do not necessarily
yield the polarity and the same effects as those observed in healthy
subjects.
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